1 / 22

Post-conditioning the human heart to reduce infarct size

Post-conditioning the human heart to reduce infarct size. Michel OVIZE Inserm E 0226 and Cardiology Hospital Lyon France. Acute Myocardial Infarction. common (  500 000 / year in USA) affects outcome : mortality disabling: heart failure. Infarct size is a determinant of mortality.

tyme
Télécharger la présentation

Post-conditioning the human heart to reduce infarct size

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Post-conditioning the human heart to reduce infarct size Michel OVIZE Inserm E 0226 and Cardiology Hospital Lyon France

  2. Acute Myocardial Infarction • common ( 500 000 / year in USA) • affects outcome : mortality • disabling: heart failure

  3. Infarct size is a determinant of mortality Gibbons et al. JACC 2004;44:1533-1542

  4. Reperfusion improves outcome van Domburg et al. JACC2005:15–20

  5. stunning : accepted • arrhythmias : accepted • no-reflow : accepted • necrosis : debated Reperfusion Injury «a double edged sword»

  6. 35 30 25 * * 20 control (% of tissue area) PostC 15 PreC 10 5 0 AR/LV AN/AR Postconditioning Zhao ZQ et al. Am J Physiol 2003

  7. Ischemia Reperfusion reperfusion injury Infarct size ischemic injury time coronary occlusion PreC Postconditioning Infarction: a two-component damage

  8. Current treatment of AMI • -blockers • ACE inhibitors • statins • …. improve post-MI outcome, but not via a reduction in infarct size • Ischemic damage : YES • thrombolysis / PCI ischemia time • antiplatelet agents ischemia time • Reperfusion damage : NO Action on infarct size

  9. Loosing protection A narrow time window

  10. Does Postconditioning protect the human heart ? A « proof of concept » study

  11. Study population A « Human Model » of Postconditioning • Inclusion criteria • Age ≥ 18 • First acute (STE)MI / chest pain onset < 6 hrs • Need for emergency PTCA • Exclusion criteria • Cardiac arrest • Cardiogenic shock • Circumflex coronary artery as culprit for AMI

  12. Experimental Design Eligible Patient TIMI 0 Collat = 0 Coronary + LV Angio Informed consent Randomization Angioplasty reperf. TIMI > 2

  13. Occluded coronary artery Reperfusion Control Direct stenting 1’ 1’ 1’ 1’ Postcond 1’ 1’ 1’ 1’ Balloon inflations - deflations Post-Conditioning algorythm Staat et al. Circulation. 2005;112:2143-2148

  14. Study Endpoints • Total CK release over first 72 hrs of reperfusion • every 4 hr on Day 1 • every 6 hr on Day 2 • every 8 hr on Day 3

  15. Results

  16. Study population - baseline characteristics

  17. Length of the Abnormally Contracting Segments of the LVED endocardial perimeter Length of the LVED endocardial perimeter LV End Diastole A B LV End Systole B - C A - D D C Area at Risk estimation on LV angiogram Anterior infarct ACS = X 100 %

  18. (%) 50 ns min. 500 40 ns 400 30 300 20 control PostC 200 PostC control Determinants of infarct size Area at Risk size (ACS) Duration of Ischemia

  19. Control Post-Cond CK release during reperfusion 5000 4000 - 36 % (p < 0.05) 3000 CK release (AUC: arbitrary units) 2000 1000 0 4h 8h 24h 48h 72h Adm. Reperfusion PTCA Staat et al. Circulation. 2005;112:2143-2148

  20. 9.105 8. 105 7.105 Control 6.105 5.105 PostC CK release (AUC) 4.105 3.105 2.105 1.105 0 0 20 40 60 ACS (%) CK release versus ACS (infarct size versus area at risk)

  21. 3 * 3 2,5 2 2 Blush grade ST segment shift (mm) 1,5 1 1 0,5 0 0 PostC PostC C C Estimation of « no reflow » Staat et al. Circulation. 2005;112:2143-2148

  22. Toward New Clinical Strategies Ischemic PostC PCI - thrombolysis Pharmaco PostC adenosine, NO, K+ATP openers survival kinases mPTP inhibitors, ….. drug

More Related